NPJP Stock Overview
A commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Nephros, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.40 |
| 52 Week High | US$3.49 |
| 52 Week Low | US$1.40 |
| Beta | 1.18 |
| 11 Month Change | -14.11% |
| 3 Month Change | -25.93% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -27.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| NPJP | DE Machinery | DE Market | |
|---|---|---|---|
| 7D | -10.8% | -1.4% | -1.9% |
| 1Y | n/a | 17.7% | 12.3% |
Return vs Industry: Insufficient data to determine how NPJP performed against the German Machinery industry.
Return vs Market: Insufficient data to determine how NPJP performed against the German Market.
Price Volatility
| NPJP volatility | |
|---|---|
| NPJP Average Weekly Movement | 6.0% |
| Machinery Industry Average Movement | 4.1% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NPJP has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: NPJP's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 31 | Robert Banks | www.nephros.com |
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment.
Nephros, Inc. Fundamentals Summary
| NPJP fundamental statistics | |
|---|---|
| Market cap | €15.18m |
| Earnings (TTM) | -€1.18m |
| Revenue (TTM) | €12.55m |
1.2x
P/S Ratio-12.9x
P/E RatioIs NPJP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NPJP income statement (TTM) | |
|---|---|
| Revenue | US$13.77m |
| Cost of Revenue | US$5.46m |
| Gross Profit | US$8.31m |
| Other Expenses | US$9.61m |
| Earnings | -US$1.29m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 60.38% |
| Net Profit Margin | -9.40% |
| Debt/Equity Ratio | 0% |
How did NPJP perform over the long term?
See historical performance and comparison